If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
59.80    2.80 (4.91%)
Bid:
57.20
Ask:
60.00
Spread: 2.80 (4.895%)
Market Cap: £48.70m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Update

27 Mar 2008 07:02

Flomerics Group PLC27 March 2008 Flomerics Group PLC ("Flomerics" or "the Company") Update Flomerics, the global supplier of specialist simulation software for electronicsand fluid flow simulation, is today providing an update on its operational plansand outlook for 2008 and beyond in the light of the recent changes inshareholdings in the Company. Flomerics' strategy remains to be a leading provider of software simulationsolutions to the worldwide engineering design market. Flomerics' softwaresolutions are targeted at the world electronic thermal management and fluid flowsoftware markets. These markets are growing strongly and the Company believes it has significantopportunities for growth. For example, data published by Global IndustryAnalysts, Inc.(1) indicates that the world electronic thermal managementsoftware market will continue to grow by 10% per year over the next five years.The Company's electronics cooling business is well positioned to benefit fromthis growth, particularly in Asia and the Far-East, which has seen strong growthin recent years. Similarly, the computer-aided engineering industry is expected to grow at acompound annual growth rate of 12% through 2009(2). The Board believesFlomerics' products can outperform this average market growth rate due to thecompetitive advantages offered by its products. Strong growth has already beenseen for the Engineering Fluid Dynamics (EFD) product range in 2007 and into2008. The investment in sales and marketing in 2007, aimed at accelerating revenuegrowth particularly from the EFD product range (acquired as part of theacquisition of Nika GmbH in 2006) is beginning to show positive results. Thisreinforces the Board's confidence that 2008 revenues will show considerableimprovement over 2007. Flomerics has cash balances of approximately £5.0m compared to £2.7m as at 31December 2007, and the Company is well funded to undertake the investment neededto deliver its strategy. Following on from the acquisitions of MicReD in 2005and Nika GmbH in 2006, additional growth through targeted acquisition remains animportant focus for the Company. The board continues to review potentialcandidates against its strategic and financial targets. The Company expects to announce its preliminary results for 2007 on 29 April. Enquiries: Flomerics Group plc +44 20 8487 3000Gary Carter, Chief ExecutiveKeith Butcher, Finance Director Conduit PR +44 20 7429 6604Christian Taylor-Wilkinson, Charlie Geller +44 7970 067320 Oriel Securities Limited +44 20 7710 7600Nominated AdviserDavid ArchAndrew Edwards For further details regarding the source information used in this announcementplease contact Charlie Geller, Conduit PR, on 0207 429 6604 -------------------------- (1) Source: PRWeb(2) Source: Daratech Inc This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Nov 20217:00 amRNSHolding(s) in Company
10th Nov 20214:09 pmRNSHolding(s) in Company
3rd Nov 20214:41 pmRNSSecond Price Monitoring Extn
3rd Nov 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20217:00 amRNS2021 HALF-YEAR REPORT - six months to 30 June 2021
3rd Aug 20217:00 amRNSGroup Trading Update & Notice of Half-year Results
13th Jul 20215:06 pmRNSHolding(s) in Company
30th Jun 20215:16 pmRNSHolding(s) in Company
3rd Jun 20211:27 pmRNSResult of AGM &Total Voting Rights
1st Jun 20219:49 amRNSImplementation of LTIP and Grant of Options
24th May 20218:36 amRNSHolding(s) in Company - Correction
24th May 20218:36 amRNSClarification of holding in the Company
21st May 20217:00 amRNSHolding(s) in Company -CORRECTION
19th May 20215:40 pmRNSHolding(s) in Company
7th May 20212:11 pmRNSAvailability of the Annual Report & Notice of AGM
6th May 202112:22 pmRNSHolding(s) in Company
22nd Apr 20217:00 amRNSDirector/PDMR Shareholding
20th Apr 20217:00 amRNS2020 Annual Results - Current Trading & Outlook
25th Mar 20217:00 amRNSNotice of Preliminary Results
27th Jan 20212:50 pmRNSHolding(s) in Company
26th Jan 20217:00 amRNS2020 Trading Update
14th Dec 20207:00 amRNSHolding(s) in Company
23rd Nov 20205:18 pmRNSHolding(s) in Company
10th Nov 20204:35 pmRNSPrice Monitoring Extension
5th Nov 20204:41 pmRNSSecond Price Monitoring Extn
5th Nov 20204:36 pmRNSPrice Monitoring Extension
3rd Nov 20204:41 pmRNSSecond Price Monitoring Extn
3rd Nov 20204:36 pmRNSPrice Monitoring Extension
13th Oct 20207:00 amRNSHolding(s) in Company
8th Oct 20202:31 pmRNSHolding(s) in Company
7th Oct 20201:29 pmRNSHolding(s) in Company
24th Sep 20206:03 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNS2020 Half-year Report
13th Aug 20204:41 pmRNSSecond Price Monitoring Extn
13th Aug 20204:36 pmRNSPrice Monitoring Extension
7th Aug 202012:44 pmRNSHolding(s) in Company
28th Jul 20207:00 amRNSGroup Trading Update & Notice of Half-Year Results
6th Jul 20207:00 amRNSHolding(s) in Company
11th Jun 202012:45 pmRNSHolding(s) in Company
11th Jun 20207:00 amRNSResult of AGM and Total Voting Rights (TVR)
10th Jun 20207:00 amRNSAGM Statement
4th Jun 20204:41 pmRNSSecond Price Monitoring Extn
4th Jun 20204:36 pmRNSPrice Monitoring Extension
18th May 20205:44 pmRNSNotice of AGM & Posting of Annual Report
13th May 202012:39 pmRNSHolding(s) in Company
12th May 20207:00 amRNSBoard Changes
11th May 20205:29 pmRNSHolding(s) in Company
7th May 20204:55 pmRNSHolding(s) in Company
30th Apr 20207:00 amRNSAnnual results for the year ended 31 December 2019
21st Apr 20207:00 amRNSQ1 Trading update - Three months ended 31 March

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.